Business Segments · Total Assets
Life Sciences — Total Assets
Danaher Life Sciences — Total Assets decreased by 0.9% to $23.18B in Q3 2025 compared to the prior quarter.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2016
Last reportedQ3 2025
Rolls up toTotal Assets
How to read this metric
An increase typically signals capital expansion, strategic acquisitions, or investment in R&D infrastructure, while a decrease may indicate asset divestitures, impairment charges, or a shift toward a more asset-light operating model.
Detailed definition
This metric represents the total carrying value of assets specifically allocated to the Life Sciences business segment....
Peer comparison
Comparable to 'Segment Assets' or 'Identifiable Net Assets' reported by diversified industrial or life science peers, often used to calculate segment-level return on assets (ROA).
Metric ID:
dhr_segment_life_sciences_assetsHistorical Data
7 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|
| Value | $57.89B | $17.57B | $23.73B | $23.21B | $23.40B | $23.40B | $23.18B |
| QoQ Change | — | -69.6% | +35.0% | -2.2% | +0.8% | +0.0% | -0.9% |
| YoY Change | — | -69.6% | +35.0% | -2.2% | — | — | — |
Range$17.57B – $57.89B
CAGR-45.7%
Avg YoY Growth-12.3%
Median YoY Growth-2.2%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Danaher's life sciences — total assets?
- Danaher (DHR) reported life sciences — total assets of $23.18B in Q3 2025.
- What does life sciences — total assets mean?
- The total value of all assets dedicated to the Life Sciences business segment.